When pharmacology meets the microbiome: new targets for therapeutics?

Files in this item

Files Size Format View
By request of the author, access to this item is restricted. See below for more details.

When pharmacology meets the microbiome: new targets for therapeutics?

Hyland, Niall P.; Cryan, John F.
Date: 2018-11-26
Copyright: © 2018, British Pharmacological Society. Published by John Wiley & Sons, Inc. This is the accepted version of the following item: Hyland, N. P. and Cryan, J. F. (2018) 'When pharmacology meets the microbiome: new targets for therapeutics?', British Journal of Pharmacology, 175(24), pp. 4401-4403. doi:10.1111/bph.14502, which has been published in final form at https://doi.org/10.1111/bph.14502 This editorial may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Full text restriction information: Access to this article is restricted until 12 months after publication by request of the publisher.
Restriction lift date: 2019-11-26
Citation: Hyland, N. P. and Cryan, J. F. (2018) 'When pharmacology meets the microbiome: new targets for therapeutics?', British Journal of Pharmacology, 175(24), pp. 4401-4403. doi:10.1111/bph.14502
Published Version: 10.1111/bph.14502

Show full item record

This item appears in the following Collection(s)

This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement